-
The number of abortions is up in the United States. Is it because fewer people are using birth control pills?
-
A new gallery show in London features the paintings of Marc Padeu, playing with themes from Renaissance art and bringing them to his homeland of Cameroon.
-
Researchers are facing barriers to track the spread of the disease because of restrictions on grants that would allow them to track the spread in Mexico.
-
Over 1 million people a year die from diarrheal disease. Nearly half are kids under age 5. A new vaccine in trials offers great hope.
-
For years, doctors advised against hormone therapy for women in the menopausal transition. Now everyone's talking about how great it is. Is it really a wonder drug that women should all be on?
-
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
-
Supplements are a $70 billion industry that's growing fast. But there's little evidence that many supplements actually do what they promise.
-
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
-
The flu shot uses the same technology as the COVID-19 vaccines.
-
Many people may be hearing about postpartum psychosis for the first time in relation to Lindsay Clancy, the Massachusetts woman on trial for the deaths of her three children.
-
Dr. Gail Saltz explains what the Food and Drug Administration’s plans to provide an ultra-fast review of three psychedelic drugs mean, as well as the costs and benefits of these drugs.
-
The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit the mark — until this year.